Gilead Sciences, Inc.
- SEC CIK
- 0000882095
- Latest filing
- Aug 3, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 12, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 6
- −3 vs. Q3 2025
- Portfolio value
- $1.94B
- +$144.0M (+8.0%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RCUSArcus Biosciences, Inc. | COM | 31,424,760 | $748.9M | 38.7% | 00.0% | Unchanged | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 16,707,477 | $550.6M | 28.4% | 00.0% | Unchanged | History |
| ACLXArcellx, Inc. | COMMON STOCK | 6,720,803 | $438.2M | 22.6% | 00.0% | Unchanged | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 4,505,391 | $153.2M | 7.9% | 00.0% | Unchanged | History |
| KYTXKyverna Therapeutics, Inc. | COM | 4,126,119 | $38.8M | 2.0% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 9,105,451 | $5.83M | 0.3% | 00.0% | Unchanged | History |
Sold out since Q3 2025 (3)
Positions held at the end of Q3 2025 that are gone from this filing.